Ankudavičius, V. (2024). REVIEW OF FIVE YEARS OF CLINICAL DATA ON THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER WITH PEMBROLIZUMAB AND CHEMOTHERAPY IN PD-L1 EXPRESSION-NEGATIVE PATIENTS. Pulmonology and Allergology, 8(2), 201-206. https://doi.org/10.37499/PIA.1490